Early phase experience with pralatrexate (10-propargyl-10-deazaaminopterin [PRX]), a novel antifolate with high affinity for the reduced folate carrier, in patients with chemotherapy refractory lymphoproliferative malignancies Meeting Abstract


Authors: O'connor, O.; Hamlin, P.; Neylon, E.; Moskowitz, C.; Portlock, C.; Noy, A.; Sirotnak, F.; Zelenetz, A.; Mould, D.; Horwitz, S.
Abstract Title: Early phase experience with pralatrexate (10-propargyl-10-deazaaminopterin [PRX]), a novel antifolate with high affinity for the reduced folate carrier, in patients with chemotherapy refractory lymphoproliferative malignancies
Meeting Title: 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: EJC Supplements
Volume: 4
Issue: 12
Meeting Dates: 2006 Nov 7-10
Meeting Location: Prague, Czech Republic
ISSN: 1359-6349
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2006-11-01
Start Page: 141
End Page: 142
Language: English
ACCESSION: WOS:000242688500456
DOI: 10.1016/s1359-6349(06)70466-9
PROVIDER: wos
Notes: --- - Meeting Abstract: 461 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carol Portlock
    204 Portlock
  2. Craig Moskowitz
    407 Moskowitz
  3. Ariela Noy
    351 Noy
  4. Steven M Horwitz
    645 Horwitz
  5. Andrew D Zelenetz
    767 Zelenetz
  6. Paul Hamlin
    277 Hamlin
  7. Francis M Sirotnak
    184 Sirotnak
  8. Ellen Neylon
    10 Neylon